High-Grade Surface Osteosarcoma: Clinical Features and Oncologic Outcome

Background: High-grade surface osteosarcoma is an extremely rare subtype of osteosarcoma. The treatment outcome for this tumor varies in different centers. Methods: This was a retrospective study of high-grade surface osteosarcoma; clinical, radiological, and histological materials were reviewed. Re...

Full description

Bibliographic Details
Main Authors: Zhiping Deng, Zhen Huang, Yi Ding, Yongbin Su, Chung Ming Chan, Xiaohui Niu
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:Journal of Bone Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212137420300439
_version_ 1818854514661261312
author Zhiping Deng
Zhen Huang
Yi Ding
Yongbin Su
Chung Ming Chan
Xiaohui Niu
author_facet Zhiping Deng
Zhen Huang
Yi Ding
Yongbin Su
Chung Ming Chan
Xiaohui Niu
author_sort Zhiping Deng
collection DOAJ
description Background: High-grade surface osteosarcoma is an extremely rare subtype of osteosarcoma. The treatment outcome for this tumor varies in different centers. Methods: This was a retrospective study of high-grade surface osteosarcoma; clinical, radiological, and histological materials were reviewed. Results: We studied 23 patients (16 males, seven females); median age was 24 years old. All the tumors involved the lower limb, located at the diaphysis in 11 patients and at the metaphysis in 12 patients. Even though the majority of tumors were located at the surface of the bone, the medullary canal was involved in 10 patients. The microscopic findings were indistinguishable from conventional central osteosarcoma. All the patients were treated with a combination of surgery and systemic chemotherapy. Follow-up data were completed in 20 patients; follow-up duration ranged from 27 months to 182 months or until the patient died of the disease (5–104 months). Of the 20 patients, 12 died of the disease, and eight patients were alive at the time of the last follow-up. The 5-year overall survival rate was 37.6%. Conclusions: Our study revealed that the treatment outcome for this tumor shows a poor survival rate.
first_indexed 2024-12-19T07:53:55Z
format Article
id doaj.art-7145c6d91daa4b578ed9e0efe5224663
institution Directory Open Access Journal
issn 2212-1374
language English
last_indexed 2024-12-19T07:53:55Z
publishDate 2020-08-01
publisher Elsevier
record_format Article
series Journal of Bone Oncology
spelling doaj.art-7145c6d91daa4b578ed9e0efe52246632022-12-21T20:30:03ZengElsevierJournal of Bone Oncology2212-13742020-08-0123100288High-Grade Surface Osteosarcoma: Clinical Features and Oncologic OutcomeZhiping Deng0Zhen Huang1Yi Ding2Yongbin Su3Chung Ming Chan4Xiaohui Niu5Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Peking University, Beijing, ChinaDepartment of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Peking University, Beijing, ChinaDepartment of Pathology, Beijing Jishuitan Hospital, Peking University, Beijing, ChinaDepartment of Radiology, Beijing Jishuitan Hospital, Peking University, Beijing, ChinaDivision of Orthopaedic Oncology, Department of Orthopaedic Surgery and Rehabilitation, University of Florida, Gainesville, Florida, USADepartment of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Peking University, Beijing, China; Corresponding Author.Background: High-grade surface osteosarcoma is an extremely rare subtype of osteosarcoma. The treatment outcome for this tumor varies in different centers. Methods: This was a retrospective study of high-grade surface osteosarcoma; clinical, radiological, and histological materials were reviewed. Results: We studied 23 patients (16 males, seven females); median age was 24 years old. All the tumors involved the lower limb, located at the diaphysis in 11 patients and at the metaphysis in 12 patients. Even though the majority of tumors were located at the surface of the bone, the medullary canal was involved in 10 patients. The microscopic findings were indistinguishable from conventional central osteosarcoma. All the patients were treated with a combination of surgery and systemic chemotherapy. Follow-up data were completed in 20 patients; follow-up duration ranged from 27 months to 182 months or until the patient died of the disease (5–104 months). Of the 20 patients, 12 died of the disease, and eight patients were alive at the time of the last follow-up. The 5-year overall survival rate was 37.6%. Conclusions: Our study revealed that the treatment outcome for this tumor shows a poor survival rate.http://www.sciencedirect.com/science/article/pii/S2212137420300439OsteosarcomaBone sarcomaNeoplasmChemotherapyOncology
spellingShingle Zhiping Deng
Zhen Huang
Yi Ding
Yongbin Su
Chung Ming Chan
Xiaohui Niu
High-Grade Surface Osteosarcoma: Clinical Features and Oncologic Outcome
Journal of Bone Oncology
Osteosarcoma
Bone sarcoma
Neoplasm
Chemotherapy
Oncology
title High-Grade Surface Osteosarcoma: Clinical Features and Oncologic Outcome
title_full High-Grade Surface Osteosarcoma: Clinical Features and Oncologic Outcome
title_fullStr High-Grade Surface Osteosarcoma: Clinical Features and Oncologic Outcome
title_full_unstemmed High-Grade Surface Osteosarcoma: Clinical Features and Oncologic Outcome
title_short High-Grade Surface Osteosarcoma: Clinical Features and Oncologic Outcome
title_sort high grade surface osteosarcoma clinical features and oncologic outcome
topic Osteosarcoma
Bone sarcoma
Neoplasm
Chemotherapy
Oncology
url http://www.sciencedirect.com/science/article/pii/S2212137420300439
work_keys_str_mv AT zhipingdeng highgradesurfaceosteosarcomaclinicalfeaturesandoncologicoutcome
AT zhenhuang highgradesurfaceosteosarcomaclinicalfeaturesandoncologicoutcome
AT yiding highgradesurfaceosteosarcomaclinicalfeaturesandoncologicoutcome
AT yongbinsu highgradesurfaceosteosarcomaclinicalfeaturesandoncologicoutcome
AT chungmingchan highgradesurfaceosteosarcomaclinicalfeaturesandoncologicoutcome
AT xiaohuiniu highgradesurfaceosteosarcomaclinicalfeaturesandoncologicoutcome